|
Market Closed -
Other stock markets
|
After hours 20:00:00 | |||
| 107.74 USD | +0.80% |
|
111.43 | +3.42% |
| 07-24 | UBS Adjusts Price Target on CVS Health to $122 From $115, Maintains Buy Rating | MT |
| 07-23 | Cigna aims to save $200m through artificial intelligence |  |
| Market Cap | 137B 121B 112B 103B 194B 13,238B 197B 1,333B 521B 6,508B 516B 505B 22,503B | P/E 2026 * |
17.2x | P/E 2027 * | 14.9x |
|---|---|---|---|---|---|
| Enterprise Value | 193B 170B 158B 145B 272B 18,609B 276B 1,874B 732B 9,149B 725B 710B 31,631B | EV / Sales 2026 * |
0.47x | EV / Sales 2027 * | 0.44x |
| Free-Float |
71.2% | Yield 2026 * |
2.47% | Yield 2027 * | 2.54% |
Last Transcript: CVS Health Corporation
| 1 day | +0.80% | ||
| 1 week | +0.25% | ||
| Current month | +4.15% | ||
| 1 month | +5.76% | ||
| 3 months | +38.23% | ||
| 6 months | +29.79% | ||
| Current year | +35.76% |
| 1 week | 106 |  | 110.68 |
| 1 month | 101.78 | | 110.68 |
| Current year | 69.51 | | 110.68 |
| 1 year | 58.99 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
Ali Keshavarz
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/26/26 | Tax | Controller/Auditor | -454 | 0.0000% | ||
| 5/31/26 | Tax | Chief Technology Officer | -7,618 | 0.0006% | ||
| 5/31/26 | Tax | Chief Financial Officer | -2,478 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | +0.25% | +83.39% | +41.86% | 137B | |
| +1.51% | +2.97% | +11.92% | +34.02% | 84.78B | |
| +2.22% | +4.96% | +3.79% | +56.43% | 28.09B | |
| -0.02% | +8.15% | +32.55% | +58.21% | 25.15B | |
| +1.32% | 0.00% | -14.44% | -27.43% | 20.05B | |
| +17.17% | +19.64% | +57.16% | +203.29% | 20.09B | |
| +0.50% | -0.65% | +62.63% | +130.60% | 15.12B | |
| -0.86% | -6.71% | +2.39% | -7.05% | 14.49B | |
| +0.65% | +2.44% | -5.50% | -10.95% | 13.07B | |
| -0.20% | -0.75% | -14.66% | +76.74% | 10.93B | |
| Average | +2.31% | +3.03% | +21.92% | +55.57% | 36.92B | |
| Weighted average by Cap. | +1.82% | +2.55% | +40.64% | +48.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 409B 360B 334B 307B 577B 39,428B 585B 3,971B 1,551B 19,384B 1,537B 1,504B 67,021B | 427B 375B 349B 320B 601B 41,093B 610B 4,139B 1,617B 20,203B 1,602B 1,567B 69,852B |
| Net income | 8.04B 7.07B 6.57B 6.03B 11.33B 775B 11.5B 78.03B 30.49B 381B 30.2B 29.55B 1,317B | 9.35B 8.21B 7.63B 7.01B 13.16B 900B 13.37B 90.65B 35.42B 442B 35.09B 34.33B 1,530B |
| Net Debt | 55.76B 48.98B 45.55B 41.8B 78.53B 5,370B 79.74B 541B 211B 2,640B 209B 205B 9,128B | 52.15B 45.8B 42.6B 39.09B 73.44B 5,022B 74.57B 506B 198B 2,469B 196B 192B 8,537B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | US$107.74 | +0.80% | 5,370,540 |
| 26-07-23 | US$106.89 | -1.10% | 5,823,895 |
| 26-07-22 | US$108.08 | -2.28% | 9,536,251 |
| 26-07-21 | US$110.60 | +2.78% | 9,856,298 |
| 26-07-20 | US$107.61 | +0.13% | 6,628,846 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
